Table 1.
First Author, Year | Study Type | Population | Vitamin D Parameter | Outcome | Reported Interaction with Vitamin D |
---|---|---|---|---|---|
Studies in animals | |||||
Salum, 2013 [31] | Experimental | Diabetic rats | Vitamin D supplementation | Carboxymethylycin accumulation | Negative, significant |
Ellam, 2014 [28] | Experimental | Apolipoprotein E knockout mice | Induced deficiency | Atheroma calcification | Positive, significant |
Yin, 2015 [24] | Experimental | Hypercholesterolemic swine | Induced deficiency | Macrophage recruitment | Positive, significant |
Chen, 2016 [25] | Experimental | Hypercholesterolemic swine | Induced deficiency | NFkB activity | Positive, significant |
Chang, 2017 [72] | Experimental | Obese rats | Induced deficiency | Macrophage recruitment | Positive, significant |
Farhangi, 2017 [30] | Experimental | Obese rats | Induced deficiency | Superoxide dismutase/Catalase activity | Negative, significant |
Hadjadj, 2019 [27] | Experimental | Hyperandrogenic female rats | Induced deficiency | LAD relaxation capacity | Negative, significant |
Studies in humans | |||||
Hsia, 2007 [34] | Experimental, clinical | Postmenopausal women | Vitamin D supplementation | Major adverse cardiovascular events / Stroke | Non-significant |
Giovanucci, 2008 [19] | Observational clinical | Healthy adult men | Baseline concentrations | Major adverse cardiovascular events | Inverse, significant |
Cauley, 2013 [35] | Post-hoc experimental, clinical | Postmenopausal women | Vitamin D supplementation | All-cause mortality | Non-significant |
Martins, 2014 [76] | Experimental, clinical | Obese Adults | Vitamin D supplementation | Arterial stiffness | Inverse, significant |
Schöttker, 2014 [22] | Meta-analysis | General population | Baseline concentrations | Cardiovascular mortality | Inverse, significant |
Welles, 2014 [20] | Observational clinical | Stable cardiovascular disease | Baseline concentrations | Major adverse cardiovascular events | Inverse, significant |
Sunbul, 2015 [29] | Observational | Healthy adults | Baseline concentrations | Global longitudinal strain | Statistically significant |
Faridi, 2017 [23] | Observational clinical | General population | Baseline concentrations | Total cholesterol | Inverse, significant |
Scragg, 2017 [36] | Experimental, clinical | General population | Vitamin D supplementation | Cardiovascular disease incidence | Non-significant |
Zhang, 2017 [21] | Meta-analysis | General population | Baseline concentrations | Cardiovascular mortality | Inverse, significant |
Manson, 2019 [37] | Experimental, clinical | General population | Vitamin D supplementation | Major adverse cardiovascular events / Stroke | Non-significant |
NFkB: nuclear factor kappa beta; LAD: left anterior descending artery.